All News

Long-Term Findings Confirm Addition of Radiotherapy to Standard of Care in Metastatic Prostate Cancer Improves Survival

August 24th 2022

Radiotherapy with standard of care for the treatment of patients with low-burden metastatic prostate cancer had minimal effects on quality of life over a five-year follow-up period.

A Cancer Lesson Learned from a Funky Pair of Shoes

August 24th 2022

Among the many lessons I’ve learned since my diagnosis with cancer, there’s one in particular that I refer to daily. It’s a lesson learned from wearing a pair of odd-looking shoes.

Metastases Size May Indicate Which Patients With Melanoma Will Benefit from Post-Surgical Treatment

August 24th 2022

Patients with stage 3 melanoma who had metastases larger than 0.3 millimeters had poorer survival outcomes and may benefit from adjuvant therapy, recent findings showed.

Majority of Patients with Mesothelioma Subtype Responded to Keytruda-Lenvima Combo

August 24th 2022

Patients with malignant pleural mesothelioma tended to have prolonged benefit when treated with Keytruda plus Lenvima in the PEMMELA clinical trial.

FDA Stops Study of Novel Blood Cancer Drug

August 23rd 2022

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

I Refused to Let My Stage 4 Cancer Be a Death Sentence

August 23rd 2022

When doctors told me that there was no more they could do for my stage 4 lung cancer, I refused to believe them, and wish other patients did the same.

I’m Irked by the Cancer Stereotypes Portrayed on TV

August 23rd 2022

From bald heads paired with lush eyebrows to the typical emaciated patient, there are certain tropes of how cancer is portrayed on TV that bother me, as they do not represent the experiences of everyone with the disease.

Here’s How Cancer Survivors Cope With Fear of Recurrence

August 23rd 2022

CURE® surveyed its audience to see how they cope with fear of cancer recurrence. Here’s what they had to say.

Ayvakit Improves Disease Burden, Quality of Life in Mastocytosis

August 23rd 2022

Treatment with Ayvakit was associated with promising outcomes in patients with mastocytosis, according to findings from the PIONEER trial.

The Hard Truth About Young Women Facing Breast Cancer

August 22nd 2022

My doctor once told me that if you're old enough to fight for your country, then you're old enough to get breast cancer.

First Patient Receives Investigational Cancer Drug-Combination for Relapsed/Refractory Acute Myeloid Leukemia

August 22nd 2022

Adding the investigational cancer drug lanraplenib to Xospata, if found to be effective, may broaden treatment options for patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.

A Letter to Those Newly Diagnosed With Cancer, Including My Younger Self

August 22nd 2022

As I reflect on four years of “warriorhood” since being diagnosed with cancer, I wrote a letter to my younger self and others who are just receiving diagnosis.

Unraveling the Layers of Metastatic Breast Cancer

August 22nd 2022

The death of “Grease” star Olivia Newton-John from metastatic breast cancer has triggered discussions about the specifics of the disease. Here, CURE® details what metastatic breast cancer is.

Revlimid-Rituxan Combo May Offer Alternative to Chemotherapy for Lymphoma Subtype

August 22nd 2022

The combination treatment demonstrated survival and safety results similar to those of chemotherapy for patients with advanced, untreated follicular lymphoma.

What Makes an Oncology Nurse Great

August 21st 2022

Janet M. McFadden, RN-BC, B.S., MT(ASCP) understands the medical issues her patients are facing. She is calm and compassionate with her patients.

The Nurse Every Patient Needs to Get Through the Journey

August 20th 2022

Often patients read online profiles of medical providers to decide where to receive care. In reality, having a nurse like Christine is so much more important.

FDA Lifts Partial Hold on Trial Investigating Emavusertib in Lymphoma

August 19th 2022

The FDA has allowed the manufacturer of emavusertib to continue a phase 1/2 study investigating effects of the treatment in patients with lymphoma.

I’m In a Great Place With My Cancer Despite Feeling 25 Years Older Than I Am

August 19th 2022

I am still here fighting, fighting hard and I will continue to do so to make sure I have more graduations, more weddings, and more everything that I can squeeze into my precious time left here on earth.

ESPN Analyst Dick Vitale Announces He is Cancer-Free, WHO Deems Firefighting a Cancer-Causing Profession and More

August 19th 2022

From ESPN analyst Dick Vitale announcing he is cancer-free months following a lymphoma diagnosis to a Speedo-clad race in South Africa to raise awareness for cancer, here’s what’s happening in the oncology space this week.

A Total Package of Compassion and Commitment for Patients With Cancer

August 19th 2022

Not only does she have incredible clinical intuition and ability, but she has a deep compassion and commitment to her patients that is truly unparalleled.

First Patient Receives Treatment With Investigational CAR-T Cell Therapy-Opdivo Combo for Hodgkin Lymphoma

August 18th 2022

A representative of the company developing the investigational CAR-T cell therapy noted that they hypothesize that the combination “has the potential to further enhance efficacy and provide patients with a chemotherapy-sparing, second-line treatment option.”

New Study to Explore Safety and Efficacy of a Single-Infusion CAR-T Cell Treatment in Patients With Colon Cancer

August 18th 2022

Investigators plan to analyze if treatment with an experimental, CAR-T cell therapy is safe and effective in a small group of patients with relapsed or refractory metastatic colorectal cancer.

I Don’t Regret My Choice to Forgo Chemotherapy

August 18th 2022

My choice to not undergo chemotherapy for breast cancer was not an easy one, but looking back, I don’t regret it.

FDA OKs New Drug Application for Momelotinib to Treat Myelofibrosis

August 18th 2022

The FDA has set a date to decide whether or not to approve momelotinib for myelofibrosis, a rare type of blood cancer.

A One-in-a-Million Oncology Nurse Practitioner

August 18th 2022

Like all good oncology nurse practitioners, she has a deep knowledge of cancer medicine, and I would trust her to care for anyone in my family.

FDA Grants Priority Review to Lynparza-Based Combination for Metastatic Prostate Cancer

August 17th 2022

If approved, the Lynparza-based regimen would become the first combination of a PARP inhibitor and a hormonal agent for metastatic castration-resistant prostate cancer.

Patient With Metastatic Breast Cancer Recalls Witness of Data Leading to Enhertu Approval in HER2-Low Disease

August 17th 2022

A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.

I’m Still Alive With Cancer, But I Want More

August 17th 2022

Cancer and COVID-19 took away my yearly “benchmarks” of time, when I fly out to see friends and family.

Was My Cancer Diagnosis Really a Fluke Like My Oncologist Said?

August 17th 2022

Prior to my breast cancer diagnosis, my only goal in life was for my son to turn 16 so he could drive me to and from the local bars. Now I can’t help but think that my cancer was meant for me to change my life.

Patient and Oncology Nurse Empowerment

August 17th 2022

Janet brings our values at Fox Chase Cancer Center to life.